Aquestive Therapeutics (AQST) Reports Q1 Loss, Lags Revenue Estimates

• click to rate

  Posted by Two Blokes May 12 - Filed in Stock - 8 views
  
  Aquestive Therapeutics (AQST) came out with a quarterly loss of $0.24 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares to loss of $0.17 per share a year ago.